Definitive Additional Materials

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant x                            Filed by a Party other than the Registrant ¨

Check the appropriate box:

 

¨    Preliminary Proxy Statement
¨    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨    Definitive Proxy Statement
x    Definitive Additional Materials
¨    Soliciting Material under §240.14a-12

BioMarin Pharmaceutical Inc.

(Name of Registrant as Specified In Its Charter)

 

 

 

(Name of Person(s) Filing Proxy Statement if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

 

x    No fee required.
¨    Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  

(1) Title of each class of securities to which transaction applies:

 

  

(2) Aggregate number of securities to which transaction applies:

 

  

(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

  

(4) Proposed maximum aggregate value of transaction:

 

  

(5) Total fee paid:

 

¨    Fee previously paid with preliminary materials.
¨    Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  

(1) Amount previously paid:

 

  

(2) Form, Schedule or Registration Statement No.:

 

  

(3) Filing Party:

 

  

(4) Date Filed:

 


*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on May 15, 2013

 

    

 

 

 

BIOMARIN PHARMACEUTICAL INC.

              

 

Meeting Information

           

 

Meeting Type: Annual Meeting

 

For holders as of: March 18, 2013

 

Date: May 15, 2013            Time: 9:00 AM PDT

    
  

LOGO

BIOMARIN PHARMACEUTICAL INC.

105 DIGITAL DR. NOVATO,

CA 94949

        

 

Location:

 

 

Cavallo Point Lodge

 

601 Murray Circle-Fort Baker

 

Sausalito, CA

 

94965

 

    

LOGO

           

 

You are receiving this communication because you hold shares in the above named company.

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

           

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

           

 

See the reverse side of this notice to obtain proxy materials and voting instructions.

 

           


   

Before You Vote

How to Access the Proxy Materials

 

      Proxy Materials Available to VIEW or RECEIVE:
     

1. related Notice & Proxy Statement    2. Form 10-K      3. CEO Stockholder Letter

How to View Online:

 

Have the information that is printed in the box marked by the arrow         LOGO    (located on the following page) and visit: www.proxyvote.com.

How to Request and Receive a PAPER or E-MAIL Copy:

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

1) BY INTERNET:        www.proxyvote.com

2) BY TELEPHONE:    1-800-579-1639

3) BY E-MAIL*:            sendmaterial@proxyvote.com

*  If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow         LOGO    (located on the following page) in the subject line.

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 01, 2013 to facilitate timely delivery.

 

    
           

 

 

LOGO

   

 

How To Vote

Please Choose One of the Following Voting Methods

 

       
     

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow     LOGO          available and follow the instructions.

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

    
                 
           


    Voting items     
  The Board of Directors recommends you vote
     FOR all of the following Director nominees:
  1.  Election of Directors            
            Nominees            
  01  Jean-Jacques Bienaimé    02  Michael Grey    03  Elaine J. Heron    04  Pierre Lapalme    05  V. Bryan Lawlis
  06  Richard A. Meier    07  Alan J. Lewis    08  William D. Young    09  Kenneth M. Bate   
 

 

The Board of Directors recommends you vote FOR proposals 2, 3 and 4.

 

  2   To approve an amendment to BioMarin’s 2006 Share Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan from 23,000,000 to 31,000,000 and to make certain other modifications to such plan as disclosed in its Proxy Statement.
  3   To vote on an advisory basis to approve the compensation of BioMarin’s Named Executive Officers, as disclosed in its Proxy Statement.
  4   To ratify the selection of KPMG LLP as the independent registered public accounting firm for BioMarin for the fiscal year ending December 31, 2013.
  NOTE: Your proxy holder will also vote on any other business as may properly come before the meeting or any adjournment thereof.

 

 

LOGO


 

 

 

 

 

 

 

 

 

 

 

LOGO